Robert Z. Orlowski, MD, PhD
At Texas MD Anderson Cancer Center, Dr. Orlowski holds the Florence Maude Thomas Cancer Research Professorship in the Department of Lymphoma/Myeloma, and also of Experimental Therapeutics, and serves as the Chair, ad interim, for Lymphoma/Myeloma. He obtained an MD from the Yale University School of Medicine and a PhD from Yale University Graduate School. Prior to arriving at MD Anderson, he was the Lenvel Lee Rothrock Associate Professor in Hematology/Oncology and Pharmacology at the University of North Carolina at Chapel Hill’s Lineberger Comprehensive Cancer Center. Currently, Dr. Orlowski leads both laboratory- and clinically-based research programs studying hematologic malignancies, with a focus on multiple myeloma. Dr. Orlowski’s research has been recognized through receipt of a number of awards, including a Young Investigator Award from the American Society of Clinical Oncology, and the Celgene Young Investigator Award for Achievements in Clinical Hematology Research. He has authored over 200 abstracts and publications, and serves as a reviewer on a number of study sections, and for several journals, including Blood, Cancer Cell, Cancer Research, the Journal of Clinical Oncology, Nature Medicine, and the New England Journal of Medicine.